Prevalence of helicobacter pylori infection and gastroscopic finding in diabetic patients: A case-control study

##plugins.themes.academic_pro.article.main##

Rafik Jmaa
Ali Jmaa
Aida Ben Slama Trabels
Aida Ben Slama Trabelsi
Belgacem Issaoui
Belgacem Issaoui
Ahlem Souguir
Ahlem Souguir
Mehdi Ksiaa
Mehdi Ksiaa
Moncef Mokn
Moncef Mokni
Salem Ajmi
Salem Ajmi

Abstract

Background: Current data on the prevalence of Helicobacter pylori infection in dyspeptic diabetic patients are contradictory in the literature.

Aim: the aim was to assess the prevalence of Helicobacter pylori infection, gastroscopic lesions, and gastric histopathological lesions, in dyspeptic diabetic patients.

Methods: It was a case-control study collecting 394 dyspeptic patients (194 diabetic and 200 nondiabetic patients).

Results: The average age of patients was 47 years. 144 patients (47%) were male and 150 patients (53%) were female. The two patient groups were matched for age and sex. The prevalence of Helicobacter pylori infection was comparable between the two groups of patients (85% in diabetics versus 90% in the controls). The frequency of gastroscopic lesions was 50% in diabetics and 55% in controls with no significant difference between the two groups. At histology, the prevalence of chronic gastritis, intestinal metaplasia, and gastric atrophy was 85%, 13% and 39% respectively in the group of diabetic patients. These results were comparable to those found in patients without diabetes.

Conclusion: Our work shows no difference between diabetics and non-diabetics on the prevalence of Helicobacter pylori infection, gastroscopic, and gastric histopathological lesions.

Keywords:

Helicobacter pylori - diabetes mellitus - prevalence

##plugins.themes.academic_pro.article.details##

References

  1. en Ammar A, Cheikh I, Kchaou M, Chouaib S, Ouerghi H, Chaâbouni H. Prevalence of Helicobacter pylori infection in normal or asymptomatic patients. Tunis Med. 2003 81:200-4
  2. Correa P. The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res 1980; 6: 98-108
  3. Correa P. Chronic gastritis as a cancer precursor. Scand Gastroenterol 1984; 104:131-6.
  4. Consensus tunisien de prévention et prise en charge du diabète de type 2. 2 ème édition 2009.
  5. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.Am J Surg Pathol 1996; 20: 1161-81
  6. Simon L, Tornoczky J, Toth M, Jámbor M, Sudár Z. The significance of Campylobacter pylori infection in gastroenterologic and diabetic practice. Orv Hetil 1989;130:1325-9
  7. Oldenburg B, Diepersloot RJ, Hoekstra JB. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 1996; 41: 458-61.
  8. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G. Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. Microbiologica 1996;19:149-54
  9. Gentile S, Turco S, Oliverio B, Torella R. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998; 42:41-8
  10. Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study. Int J Diabetes Dev Ctries. 2010 ; 30: 22-6.
  11. Zelenkova J, Souckova A, Kvapil M, Soucek A, Vejvalka J, Segethova J. Helicobacter pylori and diabetes mellitus. Cas Lek Cesk. 2002; 141:575-7.
  12. Woodward M, Morrison C, McColl K. An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 2000; 53:175-81
  13. Xia HH, Talley NJ, Kam EP, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96: 1039-46
  14. Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A. Helicobacter pylori infection in diabetic patients: prevalence and endoscopic findings. Eur J Intern Med 2002 ; 13:376
  15. Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U. Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci. 2008 ;53:2646-9
  16. Gasbarrini A , Ojetti V, Pitocco D et al. Helicobacter pylori infection in patients affected by insulin-dependent diabetes mellitus. Eur J Gastroenterol Hepatol 1998;10:469-472
  17. De Luis D.A., De la Calle H., Roy G. et al. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diab Res Clin Pract 1998; 39:143-6
  18. Marrollo M, Latella G, Melideo D, et al. Increased prevalence of Helicobacter pylori in patients with diabetes mellitus. Dig Liver Dis. 2001; 33:21-9.
  19. Antwi Ch, Krahulec B, Michalko L, Strbova L, Hlinstakova S, Balazovjech I. Does diabetic autonomic neuropathy influence the clinical manifestations of reflux esophagitis? Bratisl Lek Listy. 2003; 104: 139-42.
  20. Mittal RK, Holloway RH, Penagini R, Blackshaw LA, Dent J. Transient lower esophageal sphincter relaxation. Gastroenterology. 1995; 109:601-10
  21. Holloway RH, Hongo M, Berger K, McCallum RW. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology. 1985; 89: 779-784.